Skip to Main Content

Paper Details

Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Cancer Res
0
2023
ECM proteins, Metastases, Patient, Primary Tumors, TNBC, TNBC tumors, TNC, anti-TNC nanobodies, cancer, colorectal cancer, human, metastases, patient, primary and metastatic tumors, primary tumor, primary tumors, tenascin-C, tumor, tumors
Author NameAffiliation
Karl R ClauserBroad Institute of MIT and Harvard
Charles A WhittakerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Steven A CarrBroad Institute of MIT and Harvard
Steven A CarrBroad Institute of MIT and Harvard
Richard O HynesKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Richard O HynesHoward Hughes Medical Institute
  • 1 - 6

Datasets

Release 1.2